Vericel Corp
NASDAQ:VCEL

Watchlist Manager
Vericel Corp Logo
Vericel Corp
NASDAQ:VCEL
Watchlist
Price: 52.74 USD -4.92% Market Closed
Market Cap: 2.6B USD
Have any thoughts about
Vericel Corp?
Write Note

Vericel Corp
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Vericel Corp
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Vericel Corp
NASDAQ:VCEL
Revenue
$226.8m
CAGR 3-Years
14%
CAGR 5-Years
16%
CAGR 10-Years
32%
Abbvie Inc
NYSE:ABBV
Revenue
$55.5B
CAGR 3-Years
0%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$28.3B
CAGR 3-Years
1%
CAGR 5-Years
5%
CAGR 10-Years
3%
Amgen Inc
NASDAQ:AMGN
Revenue
$32.5B
CAGR 3-Years
8%
CAGR 5-Years
7%
CAGR 10-Years
5%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$10.6B
CAGR 3-Years
14%
CAGR 5-Years
24%
CAGR 10-Years
30%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.8B
CAGR 3-Years
1%
CAGR 5-Years
16%
CAGR 10-Years
18%

Vericel Corp
Revenue Breakdown

Breakdown by Geography
Vericel Corp

Not Available

Breakdown by Segments
Vericel Corp

Total Revenue: 197.5m USD
100%
Total Maci Implants And Kits: 164.8m USD
83.4%
Epicel: 31.6m USD
16%
Maci Implants And Kits: 4.9m USD
2.5%
Biopsy Kits - Direct Bill: 2.1m USD
1.1%
Show More
Show Less

See Also

What is Vericel Corp's Revenue?
Revenue
226.8m USD

Based on the financial report for Sep 30, 2024, Vericel Corp's Revenue amounts to 226.8m USD.

What is Vericel Corp's Revenue growth rate?
Revenue CAGR 10Y
32%

Over the last year, the Revenue growth was 22%. The average annual Revenue growth rates for Vericel Corp have been 14% over the past three years , 16% over the past five years , and 32% over the past ten years .

Back to Top